Month: July 2023
Understanding the Issues with ADA Assays
The biotech industry is rapidly modifying and developing biotherapeutics into complex large molecules with specificity moieties and multiple functional domains to produce a specific biological method of action. (ADC, ACC, Bi-specific antibodies, Fusion proteins, recombinant-modified proteins, etc.) Therefore, developing LBA assays to detect the immunogenicity of these biotherapeutics is becoming very complex due to this…